Hematology & Oncology Doctors in Inglewood, CA Accepting Medicare

3 Hematology & Oncology doctors found. Showing 1 - 3

Titfany Wang, MD Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 133 N Prairie Ave Ste C, Inglewood, CA 90301 Phone: 800-871-8890

Doris E Lyonga, MD Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 575 East Hardy Street, Suite 104, Inglewood, CA 90301 Phone: 310-673-9604    Fax: 310-673-3058

Robert Levin, MD Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 2220 W Manchester Blvd, Inglewood, CA 90305 Phone: 310-644-8400

News Archive

Losing sense of smell may indicate Parkinson's

Many individuals with Parkinson's disease are able to recall losing their sense of smell well before the onset of more commonly recognized symptoms such as tremors, impaired dexterity, speech problems, memory loss and decreased cognitive ability.

Stubbing out smoking in all American workplaces would save more than 2,420 lives and $280 million

Making workplaces smoke-free would prevent an estimated 610 stroke and heart attack deaths in the first year alone, mostly among non-smokers. Over seven years, the study projects that more than 2,420 lives and $280 million would be saved – not including the costs associated with other smoking-related illnesses or lost productivity.

Encouraging results from Tonix TNX-102 SL clinical trial for fibromyalgia syndrome

Tonix Pharmaceuticals Holding Corp., a specialty pharmaceutical company developing therapies for challenging disorders of the central nervous system, including fibromyalgia syndrome and post-traumatic stress disorder, announces that the clinical portion of a human study of a solution version of TNX-102 2.4 mg sublingual tablets has completed.

Eliminating sugary drinks from diet can reduce tooth decay in American Indian children

A study conducted in four American Indian communities in the Pacific Northwest presents an effective strategy to convince mothers to switch young children from drinking sweetened soda to water and shows that eliminating these sugary drinks from the diets of the youngest members of the tribe significantly decreased tooth decay.

Merck Serono to present Erbitux data at ESMO Congress

Merck Serono, a division of Merck KGaA, Darmstadt, Germany announces today that it will be presenting new data from several studies of Erbitux (cetuximab) in a range of solid tumor types including the first Phase II data in breast and prostate cancers. These data will be presented at the forthcoming 35th European Society for Medical Oncology Congress (ESMO) in Milan, October 8-12, 2010.

Read more Medical News

› Verified 8 days ago